1091-207 Primary and secondary prevention implantable cardioverter defibrillator patients have similar proportions of ventricular tachyarrhythmia detections and equivalent risk for spurious therapies: Results from painFREE Rx II
2004 ◽
Vol 43
(5)
◽
pp. A125
◽
2005 ◽
Vol 111
(22)
◽
pp. 2898-2905
◽
2008 ◽
Vol 7
◽
pp. 172-173
2015 ◽
Vol 68
(6)
◽
pp. 492-496
2009 ◽
Vol 32
◽
pp. S67-S70
◽
2020 ◽
Vol 75
(11)
◽
pp. 389